Assenagon Asset Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Sell |
648,825
-2,131
| -0.3% | -$7.91K | ﹤0.01% | 718 |
|
|
2025
Q1 | $2.1M | Sell |
650,956
-2,574
| -0.4% | -$8.31K | ﹤0.01% | 730 |
|
|
2024
Q4 | $3.64M | Sell |
653,530
-889,884
| -58% | -$4.96M | 0.01% | 746 |
|
|
2024
Q3 | $16.7M | Buy |
1,543,414
+1,087,147
| +238% | +$11.8M | 0.03% | 370 |
|
|
2024
Q2 | $9.58M | Buy |
456,267
+25,711
| +6% | +$540K | 0.02% | 417 |
|
|
2024
Q1 | $13.7M | Buy |
+430,556
| New | +$13.7M | 0.03% | 332 |
|